MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited ROA Ratio 2011-2026 | VNRX
Annual ROA Ratio VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -289.99 | -127.64 | -167.25 | -98.18 | - | -75.61 | -102.97 | -100.99 | -48.14 | -123.58 | -239.25 | -179.24 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -48.14 | -289.99 | -141.17 |
Quarterly ROA Ratio VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -265.53 | -228.41 | -210.25 | -143.9 | -190.75 | -191.33 | -171.96 | -130.69 | -164.16 | -150.77 | -147.87 | -89.59 | -113.52 | -103.99 | -88.05 | -54.87 | -71.45 | -64.1 | -67.57 | -58.27 | -77.91 | -80.96 | -81.2 | -58.91 | -84.5 | -90.46 | -97.2 | -78.46 | -105.07 | -106.09 | -103.52 | -73.21 | -87.28 | -74.72 | -62.97 | -36.07 | -74.49 | -98.84 | -111.17 | -88.74 | -260.42 | -393.69 | -345.64 | -211.81 | -256.51 | -129.52 | -203.9 | -139.12 | -256.67 | -329.52 | -320.95 | -195.73 | -271.05 | -228.81 | -215.31 | -118.75 | -75.31 | -28.51 | -14.93 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -14.93 | -393.69 | -141.95 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.71 | 0.73 % | $ 7.5 M |  USA |
 |
Illumina
ILMN
|
-19.4 | $ 123.79 | -0.43 % | $ 19.7 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.13 | -2.74 % | $ 4.89 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 25.75 | 3.0 % | $ 715 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.1 | 1.76 % | $ 1.04 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | $ 104.91 | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.51 | 1.1 % | $ 392 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 200.09 | 2.46 % | $ 19.7 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.15 | 2.68 % | $ 798 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Personalis
PSNL
|
-30.08 | $ 7.61 | 4.82 % | $ 451 M | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 158.0 | 2.86 % | $ 7.83 B | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 166.96 | 0.54 % | $ 28.7 B | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 75.73 | -0.92 % | $ 5.11 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
IDEXX Laboratories
IDXX
|
31.62 | $ 578.51 | 0.22 % | $ 46.5 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.46 | 26.96 % | $ 1.86 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 456.93 | 0.98 % | $ 13.2 B | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.62 | 2.16 % | $ 276 M | USA |
 |
Sotera Health Company
SHC
|
2.39 | $ 13.88 | 2.81 % | $ 3.94 B | USA |
 |
Agilent Technologies
A
|
11.3 | $ 112.02 | 0.65 % | $ 34.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 100.35 | 0.65 % | $ 8.28 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 31.72 | -4.52 % | $ 1.61 B | USA |
 |
DarioHealth Corp.
DRIO
|
-37.9 | $ 7.5 | -6.13 % | $ 29.9 M | Israel |
 |
Guardant Health
GH
|
-20.67 | $ 84.9 | -0.33 % | $ 10.6 B | USA |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.66 | 1.75 % | $ 432 M | USA |
 |
Psychemedics Corporation
PMD
|
-33.7 | - | -1.84 % | $ 15.3 M | USA |
 |
Neuronetics
STIM
|
-27.55 | $ 1.6 | 10.34 % | $ 106 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 239.07 | 2.87 % | $ 25.5 B |  Schweiz |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 17.56 | 2.39 % | $ 936 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 3.48 | 0.87 % | $ 1.87 M | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 478.12 | 0.79 % | $ 180 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 106.75 | 0.67 % | $ 4.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 264.42 | 0.54 % | $ 22 B | USA |